CAS: 104-78-9; 3-Diethylaminopropylamine

上下游产品

phthalimide 3-diethylaminopropyl chloride 2-(3-bromopropyl)isoindole-1,3-dione diethylamine N,N-diethyl-N'-(1,1-dioxo-tetrahydro-1λ6-[3]thienyl)-propanediyldiamineN,N-diethyl-N'-(1,1-dioxo-tetrahydro-1λ6-[3]thienyl)-propanediyldiamine 2-(3-diethylaminopropyl)-1H-isoindole-1,3(2H)-dione N-(3-diethylamino-propyl)-N'-(4-[2]pyridyl-phenyl)-thioureaN-(3-diethylamino-propyl)-N'-(4-[2]pyridyl-phenyl)-thiourea N,N-diethyl-N'-(2-phenyl-[4]quinolylmethyl)-propanediyldiamineN,N-diethyl-N'-(2-phenyl-[4]quinolylmethyl)-propanediyldiamine

3-二乙氨基丙腈置于乙醇,Sodium体系中,化学反应 3.0H,以56%的收率获得3-二乙胺基丙胺
参考文献:Nabh4在panf固定化季铵盐催化下的水中nabh4高效还原羰基,叠氮化物和苄基卤化物
标题:Nabh4在panf固定化季铵盐催化下的水中nabh4高效还原羰基,叠氮化物和苄基卤化物
摘要:制备了一系列聚丙烯腈纤维负载的季铵盐(panf-Qas),并将其用于以nabh4作为还原剂催化还原水中的醛,酮,叠氮化物和苄基卤化物.
Doi:10.1039/c5Gc02621K

专利信息

专利号:WO-0140193-A1
优先权日:1999-12-03
标题:Method for the synthesis of pyrazolines
发明人：BOLDI ARMEN M
权利人:CHEMRX ADVANCED TECHNOLOGIES I; BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula (I). Also claimed are novel intermediates and their methods of synthesis.

专利号:US-2002103381-A1
优先权日:2000-11-30
标 题 :Method for the synthesis of pyrazolines
发明人：BOLDI ARMEN M
摘要:The present invention provides a method for the synthesis of compounds of Formula I: n n n Also claimed are novel intermediates and their methods of synthesis.

专利号:WO-2016173960-A1
优先权日:2015-04-29
标 题 :Optimized synthesis of pregabalin and 4-aminobutane acid using an improved method for producing conjugated nitroalkenes
发明人：STUMPF MARCUS
权利人:K H S PHARMA HOLDING GMBH
摘要:The invention relates to an optimized synthesis of pregabalin and additional 4-aminobutane acids using an improved method for producing conjugated nitroalkenes. This is achieved by a nitro-aldol reaction of an aliphatic aldehyde with a nitroalkane in the presence of a suitable diamine directly followed by an elimination of the conjugated nitroalkene by adding an acid, a subsequent catalyzed asymmetrical 1,4-Michael addition of a suitable nucleophile, and a subsequent retro-Claisen reaction or a hydrolosis and decarboxylation with a concluding reduction to 4-aminobutane acid.

专利号:US-5541237-A
优先权日:1995-02-24
标题 :Synthesis of poly(l-leucine)
发明人：LEN CHING-HOHN; HO CHI-MAN; DENG SHU-YI; TSAI ZEI-TSAN
权利人:INST NUCLEAR ENERGY RES
摘要:The invention relates to a method for synthesis of poly(L-leucine). Without any initiator and solvent poly(L-leucine) has been made from L-leucine-N-carboxy anhydride as starting material in the solid state by irradiation with gamma ray. There is only one step in the entire synthetic processing, and the polymerization yield is 100% and the process is a very simple, safe and convenient method. The poly(L-leucine) is one of the best materials for temporary wound dressing.

专利号:US-2025129021-A1
优先权日:2023-09-19
标 题:Small molecule protein synthesis modulators
发明人：GYGI DAVID; BAHMANYAR SOGOLE SAMI; HAMANN LAWRENCE
权利人:INTERDICT BIO INC
摘要:The present disclosure provides compounds of the formulae herein (e.g., Formula (I), Formula (V)), and pharmaceutically acceptable salts thereof, which are useful for modulating protein synthesis (e.g., modulating synthesis of BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D). The present disclosure also provides pharmaceutical compositions and kits comprising the compounds, or pharmaceutically acceptable salts thereof, and methods of treating or preventing diseases or disorders (e.g., diseases or disorders associated with BCL-2, MYC, CCND1, MCL-1, ALK, KRAS-G12D) by administering to a subject in need thereof the compounds, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions thereof.

专利号:US-2025049714-A1
优先权日:2021-12-09
标题 :Synthesis of ester, carbonate, and carbamate-derived novel biodegradable ionizable lipids from methyl ricinoleate or methyl 12-hydroxystearate and its applications
发明人：ANDERSON DANIEL GRIFFITH; RHYM LUKE HYUNSIK; LI BOWEN; GORDON AKIVA; RAJITH SINGH MANAN; WITTEN JACOB
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Provided herein are compounds, such as compounds of Formula (I), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, and isotopically labeled derivatives thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein are lipids useful for delivery of polynucleotides, such as mRNA, for the treatment and/or prevention of various diseases and conditions (e.g., genetic disease, proliferative disease, hematological disease, neurological disease, liver disease, spleen disease, lung disease, painful condition, psychiatric disorder, musculoskeletal disease, a metabolic disorder, inflammatory disease, or autoimmune disease).